SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Vaivade Iveta)
 

Search: WFRF:(Vaivade Iveta) > Single nucleotide p...

  • Ignatovica, VitaUppsala universitet,Funktionell farmakologi (author)

Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population

  • Article/chapterEnglish2012

Publisher, publication year, extent ...

  • 2011-06-04
  • Springer Science and Business Media LLC,2012
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-168080
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-168080URI
  • https://doi.org/10.1007/s11033-011-0938-4DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • The purinergic 1 receptor (P2RY1) has been implicated in development of heart disease and in individual pharmacodynamic response to anticoagulant therapies. However, the association of polymorphisms in the P2RY1 gene with myocardial infarction (MI), and its associated conditions, has yet to be reported in the literature. We evaluated seven known SNPs in P2RY1 for association with MI in a Latvian population. Seven independent parameters that are related to MI [body mass index (BMI), type 2 diabetes (T2D), angina pectoris, hypertension, hyperlipidemia, atrial fibrillation and heart failure] were investigated. No significant association with MI was observed for any of the polymorphisms. Those SNPs for which the P value was close to significance were located in coding or promoter regions. Intriguingly, carriers of the minor allele in the P2RY1 gene locus showed a tendency towards higher onset age for MI, suggesting a possible protective effect of these SNPs against MI or their contribution in progression as opposed to onset. Finally, a linkage disequilibrium (LD) plot was generated for these polymorphisms in the Latvian population. The results of this study suggest that the role of P2RY1 in individuals from Latvian population is likely to be principally involved in platelet aggregation and thromboembolic diseases, and not as a significant contributing factor to the global metabolic syndrome.

Subject headings and genre

  • Purinergic receptor
  • Myocardial infarction
  • Genetic association
  • Heart diseases

Added entries (persons, corporate bodies, meetings, titles ...)

  • Latkovskis, Gustavs (author)
  • Peculis, Raitis (author)
  • Megnis, Kaspars (author)
  • Schiöth, Helgi BUppsala universitet,Funktionell farmakologi(Swepub:uu)helgschi (author)
  • Vaivade, Iveta (author)
  • Fridmanis, DavidsUppsala universitet,Funktionell farmakologi (author)
  • Pirags, Valdis (author)
  • Erglis, Andrejs (author)
  • Klovins, JanisUppsala universitet,Funktionell farmakologi (author)
  • Uppsala universitetFunktionell farmakologi (creator_code:org_t)

Related titles

  • In:Molecular Biology Reports: Springer Science and Business Media LLC39:2, s. 1917-19250301-48511573-4978

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view